Deferred Tax Assets, Net of Valuation Allowance of VYNE Therapeutics Inc. from 31 Dec 2022 to 31 Dec 2023

Taxonomy & unit: us-gaap: USD
Description: Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
Summary: VYNE Therapeutics Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2022 to 31 Dec 2023.
VYNE Therapeutics Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2023 was $0.
Source SEC data: View on sec.gov

Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)

VYNE Therapeutics Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2023	$0	$0		31 Dec 2023	10-K	01 Mar 2024	2023	FY
Q4 2022	$0			31 Dec 2022	10-K	01 Mar 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.